SZTANKE - Google Patents
KRZYSZTOF SZTANKE, ANNA SIDOR-WOJTOWICZ, JANINA TRUCHLIŃSKA, KAZIMIERZ PASTERNAKSZTANKE
View PDF- Document ID
- 16953711701466455982
- Author
- SZTANKE M
External Links
Snippet
ANNALES UNI VERSITATIS MARIAE LUBLIN - POLONIA ANNA SIDOR-WOJTOWICZ, JANINA
TRUCHLIŃSKA, KAZIMIERZ PASTERNAK, -triazine deriva Page 1 ANNALES UNI VERSITATIS
MARIAE CUR I ES К Ł ODO WS К A LUBLIN - POLONIA VOL. LIX, N 2, 159 SECTIO D 2004 …
- 150000001875 compounds 0 abstract description 20
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6066628A (en) | Non-iron metalloporphyrins and methods of use | |
| JP6085829B2 (en) | Pyrimidine gyrase and topoisomerase IV inhibitors | |
| Abdallah et al. | Design, synthesis, docking, and antimicrobial evaluation of some novel pyrazolo [1, 5-a] pyrimidines and their corresponding cycloalkane ring-fused derivatives as purine analogs | |
| Odžak et al. | Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria | |
| Modiya et al. | Synthesis and screening of antibacterial and antifungal activity of 5-chloro-1, 3-benzoxazol-2 (3 h)-one derivatives | |
| Kumar et al. | Synthesis, characterization and anti-microbial activity of some 4-thiazolidinone conjugatives | |
| EP1909912B1 (en) | Use of collismycin A as oxidative stress inhibitor | |
| Hohl et al. | International multicenter investigation of LB203W. a new fluoronaphthyridone | |
| SZTANKE | KRZYSZTOF SZTANKE, ANNA SIDOR-WOJTOWICZ, JANINA TRUCHLIŃSKA, KAZIMIERZ PASTERNAK | |
| Martins et al. | An AcrAB-mediated multidrug-resistant phenotype is maintained following restoration of wild-type activities by efflux pump genes and their regulators | |
| SZTANKE et al. | JANINA TRUCHLIŃSKA, KAZIMIERZ PASTERNAK, MAŁGORZATA SZTANKE | |
| CN112159390A (en) | Synephrine fluoroquinolone derivative and preparation method and application thereof | |
| CN117597337A (en) | Preparation method of antibacterial compounds | |
| Verbist | Quinolones: pharmacology | |
| Funda Tay et al. | Synthesis, antimicrobial activity and modeling studies of thiazoles bearing pyridyl and triazolyl scaffolds | |
| SZTANKE | KRZYSZTOF SZTANKE, KAZIMIERZ PASTERNAK, MAŁGORZATA SZTANKE, ANNA SIDOR-WOJTOWICZ, JANINA TRUCHLIŃSKA | |
| WO2000018772A1 (en) | Condensed imidazolidinones as trna synthetase inhibitors | |
| Vitiu et al. | Synthesis and biological properties of the novel coordination compound with rhodanine-3-acetic acid | |
| Shurov et al. | Synthesis and Antimicrobial Activity of 2, 5-Diaryl-8, 8-Dimethyl-3, 6, 7, 8-Tetrahydro-2 H-Pyrido [4, 3, 2-de] Cinnolin-3-Ones | |
| Zemali et al. | Synthesis of nicotine derivatives and evaluation of their anti-bacterial activity | |
| WO2000017206A1 (en) | Tetracyclic heterocycles as antimicrobial agents | |
| US20250276965A1 (en) | Process for the preparation of antibacterial compounds | |
| ES | KRZYSZTOF SZTANKE, KAZIMIERZ PASTERNAK, MAŁGORZATA SZTANKE, ANNA SIDOR-WOJTOWICZ | |
| Paek et al. | Factors affecting in vitro activity of LB20304, a new fluoroquinolone | |
| McNAMARA et al. | In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents |